The three microchip stocks in this analysis are all a bit sluggish at the moment, as I look at the premarket charts. At this ...

Explore Advanced Micro Devices, Inc.'s resilient growth amidst market challenges. Click for key insights on AI momentum, AMD ...

Nvidia faces major risks from escalating US-China trade tensions, with Chinese competitors rapidly gaining market share. Read ...

TSMC holds a crucial place in the semiconductor supply chain, and 24/7 Wall St. projects a substantial gain for the stock by ...

Wedbush expects significant value to be unlocked through Tesla’s full self-driving (FSD) technology and the rollout of its ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

The chipmaker recently reached a partnership with Saudi Arabian AI startup Humain to help build a $10 billion AI-computing infrastructure over five years, a project that could boost AMD’s role in the ...

Poor breadth is mirrored in the percentage of total shares traded that are falling versus those rising. On the NYSE, ...

From making graphics cards for personal computers (PCs) to manufacturing powerful artificial intelligence (AI) chips for the ...

Shares of Advanced Micro Devices (NASDAQ:AMD) have bounced back nicely since hitting their year-to-date low of $78.21 on ...

US stock futures slide after Moodys downgraded the countrys credit rating from “Aaa” to “Aa1,” raising alarm over Americas ...